# Axel Bex

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/axel-bex/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,639 |
| Field | Renal cell carcinoma treatment |
| h-index | 67 |
| i10-index | 254 |
| Last Known Institution | Royal Free London NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5068678186 |
| ORCID iD | https://orcid.org/0000-0002-8499-2662 |
| Works | 612 |

## Researcher papers

- [Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up](https://scholariq.org/papers/renal-cell-carcinoma-esmo-clinical-practice-guideline-for-diagnosis-treatment/)
- [European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era](https://scholariq.org/papers/european-association-of-urology-guidelines-office-rapid-reaction-group-an/)
- [Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial](https://scholariq.org/papers/adjuvant-nivolumab-plus-ipilimumab-versus-placebo-for-localised-renal-cell/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Royal Free London NHS Foundation Trust](https://scholariq.org/institutions/royal-free-london-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.